The detection pathway for coronary artery disease (CAD), while well established, involves an escalating degree of cost, time, invasiveness, patient discomfort, and risks, in order to assess a patient’s suspected CAD status.
A4L is developing and testing a machine-learned algorithm that can non-invasively detect the presence of CAD and model areas of ischemia in a single office visit without radiation or accelerating the heart. Billions of signals emitted by the heart can be measured and mathematically modeled using Phase Space Tomography – their proprietary approach to phase space. Powerful IBM cloud-based technology allows for analyses by Watson, turning the data into images of the heart that depict the diagnosis.
Epic was hired to help bring this new powerful technology to life by naming the technology platform, the lead product to detect CAD, a brand story that would change beliefs, the full range of branding, a website, and a video intended to inform and attract new investment dollars. The name selected for the technology platform is Agilytics and CorVista became the name for their product to detect CAD.
All of this work lead to establishing the belief among the target investors that CorVista (lead product) is a powerful tool that gathers, interprets and quickly converts an individual’s entire spectrum of physiologic signals into a faster, more accurate assessment than conventional testing. CorVista will transform the care pathway for CAD by providing a convenient and cost-effective system to pinpoint disease immediately.
“Great job and kudos to the team!! We are now in the World’s eye as never before. From here we have a launching pad that will take us to places never imagined.”
Don Crawford, President and CEO of Analytics 4 Life
Storytelling is how we articulate the brand in human terms. It reveals the relevant and compelling connection between a brand and its customers. And it sparks belief that ultimately changes behavior. As marketers, we can choose to make the story interesting and informational, or we can decide to make it epic.
We all start with a blank page. Before making a single mark, we collect the data, essential information that allows us to make the very best choices in planning the correct approach in crafting the strongest story.
When research guides the message and is written and designed to influence in a highly personalized manner, a story will resonate with a commanding voice that will create sustainable results.
The story we tell today could very well be the first volume of a long run for your brand. Through examining the future possibilities of the therapies, we can begin to envision the opportunities the brand may have as it matures and create campaigns that allow for expansion.
Every drug or medical device has a three-part story that begins with the science, evolves into the clinical, and ultimately becomes the story from which you launch, or the commercial story. Epic has been an effective partner in assisting across this continuum.
Although various audiences have unique information requirementsconcerning your product, Epic provides unified solutions that are expansive in their ability to address diverse concerns while upholding brand identity.
At Epic, we deploy a thorough process in translating the positioning to the ultimate campaign, exploring every attribute of the brand and its potential relationship with the audience.
There is no “B” team here at Epic. Every one that is part of our team has a rich history of success that is evident in all that we do. Experience is our greatest asset.
Thought leadership can both validate the path we’ve chosen in our marketing efforts or inspire us to think beyond what we considered possible.